The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome

Clinical and Experimental Dermatology, Supplement

Volumn 28, Issue 1, 2003, Pages 19-23

  Micali, G ^a   Lacarrubba, F ^a   Nasca, M R ^a   De Pasquale, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BLEEDING; CALCIFICATION; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CASE REPORT; EROSION; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; ODONTOGENIC CYST; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKELETON MALFORMATION; CLINICAL FEATURE; CREAM; FACE TUMOR; MIDDLE AGED; OINTMENT; SKIN TUMOR; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AMINOQUINOLINES; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 1542540020     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.7.x     Document Type: Article

References (17)

1. Crean SJ, Cunningham SJ. Gorlin's syndrome: main features and recent advances. Br J Hosp Med 1996; 56: 392-7.
2. Gorlin RJ. Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995; 13: 113-25.
3. Strutton GM. Pathological variants of basal cell carcinoma. Australas J Dermatol 1997; 38: S31-5.
4. Drake LA, Ceilley RI, Cornelison RL et al. Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 1992; 26: 117-20.
5. Kopera D, Cerroni L, Fink-Puches R, Kerl H. Different treatment modalities for the managment of a patient with the nevoid basal cell cefl carcinoma syndrome. J Am Acad Dermatol 1996; 345: 937-9.
6. Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.
7. Hengge UR, Esser S, Schultewolter T et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143: 1026-31.
8. Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002; 46: 545-8.
9. Micali G, De Pasquale R, Caltabiano R, Impallomeni R, Lacarrubba F. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatolog Treat 2002; 13: 123-7.
10. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002; 146 (Suppl.): 17-9.
11. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3: 193-203.
12. Tyring SK, Arany I, Stanley MA et al. A randomised, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998; 178: 551-5.
13. Shumack S, Robinson J, Kossard S et al. Efficacy of topical imiquimod 5% cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
14. Drehs MM, Cook-Bolden F, Tanzi EL, Weinberg JM. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Dermatol Surg 2002; 28: 427-9.
15. Beutner KR, Geisse JK, Helman D et al. Therapeutic response of basal carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-7.
16. Marks R, Gebauer K, Shumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicentre 6 week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
17. Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577-8.